Global Oral Solid Dosage Pharmaceutical Formulation Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Oral Solid Dosage Pharmaceutical Formulation market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Oral Solid Dosage Pharmaceutical Formulation market."
Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.
North America dominated the global oral solid dosage pharmaceutical formulation market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.

The global Oral Solid Dosage Pharmaceutical Formulation market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Oral Solid Dosage Pharmaceutical Formulation volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Solid Dosage Pharmaceutical Formulation market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    AstraZeneca
    Bristol-Myers Squibb
    Eli Lilly
    Gilead
    Merck
    Novartis
    Pfizer
    AbbVie
    Boehringer Ingelheim

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Immediate Release
    Extended Release
    Others

Segment by Application
    Hospital Pharmacy
    Retail Pharmacy
    Drug Stores
    Others